1.30Open1.30Pre Close0 Volume80 Open Interest10.00Strike Price0.00Turnover93.95%IV5.95%PremiumMay 16, 2025Expiry Date0.75Intrinsic Value100Multiplier16DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type-0.6146Delta0.2111Gamma7.87Leverage Ratio-0.0214Theta-0.0027Rho-4.84Eff Leverage0.0074Vega
KKR Real Estate Finance Trust Stock Discussion
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet